The London School of Hygiene & Tropical Medicine (LSHTM) is a world-leading centre for research in global health. Its mission is to improve health and health equity worldwide through excellence in research, education and translation into policy and practice. The Faculty of Infectious and Tropical Diseases encompasses the laboratory-based biomedical research of LSHTM. The spectrum of diseases studied is wide and there are major research groups with a focus on malaria, tuberculosis, several neglected tropical diseases, HIV/AIDS and other sexually transmitted diseases, vaccine development and evaluation, and vector biology. The Faculty has strong overseas links, which provide a basis for field studies and international collaborations in developed and developing countries.

Achieving interdisciplinarity

The Faculty of Infectious and Tropical Diseases engages in cross-cutting inter-disciplinary research together with partners in other Faculties ( https://www.lshtm.ac.uk/). This is focused on particular biomedical research questions and diseases, as represented by the Malaria Centre and the TB Centre, or tools for improving health, as in the Vaccine Centre or the International Diagnostics Centre. We have major collaborations with the Wellcome Trust Sanger Institute, with which several faculty members hold joint appointments. In partnership with UCL, we have recently founded the Bloomsbury Research Institute, which will lead to a significant expansion of our advanced laboratory facilities, as well as our local and international partnerships.

Investing in the future

LSHTM has invested in building core strengths to enable the growth of its internationally leading research groups in microbial pathogen biology and genomics as well as immune mechanisms, in areas relevant to human and animal pathogen research. Several recent senior appointments have been made in Emerging Infectious Diseases, Bacterial Genomics and Evolution, and Molecular Parasitology, and many projects benefit from strategic long-term support of the state of the art animal facility and category 3 containment unit to study pathogens in vivo. Development of many overseas research partnerships is enabling growth in the scale and effectiveness of population genomic and epidemiological studies to understand new disease challenges, and develop research career opportunities that are highly competitive internationally.